106
Views
4
CrossRef citations to date
0
Altmetric
Letter

Predicting in vivo effectiveness from in vitro susceptibility: A step closer to performing testing of uropathogens in human urine

Pages 714-715 | Received 02 Feb 2012, Accepted 25 Feb 2012, Published online: 08 May 2012

References

  • Breteler KK, Rentenaar RJ, Verkaart G, Sturm PD. Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 2011;43:771–6.
  • Hollick GE, Washington JA. Comparison of direct and standardized disk diffusion susceptibility testing of urine cultures. Antimicrob Agents Chemother 1976;9:804–9.
  • Doern GV, Brecher SM. The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests. J Clin Microbiol 2011;49:S11–4.
  • Cunha BA, Comer JB. Pharmacokinetic considerations in the treatment of urinary tract infections. Conn Med 1979;43:347–53.
  • McNulty CA, Richards J, Livermore DM, Little P, Charlett A, Freeman E, . Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 2006;58:1000–8.
  • Cunha BA. The clinical significance of resistant uropathogens in ambulatory urinary tract infections in women. Scand J Infect Dis 2006;38:235–6.
  • Cunha BA, Klein NC, Hamid NS. Falsely high antibiotic resistance in community-acquired E. coli UTIs requiring hospitalization. Mayo Clin Proc 2005;80:824–8.
  • Stamey TA, Fair WR, Timothy MM, Millar MA, Mihara G, Lowery YC. Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med 1974;291:1159–63.
  • Ristuccia PA, Cunha BA. Activity of antimicrobial agents at urinary concentrations against ampicillin-resistant E. coli in human urine. Adv Ther 1986;3:163–7.
  • Cunha BA. Effective antibiotic-resistance control strategies. Lancet 2001;357:1307–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.